{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:05:58Z","timestamp":1648771558579},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.transproceed.2019.01.079","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:09:55Z","timestamp":1548907795000},"page":"896-900","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms"],"prefix":"10.1016","volume":"51","author":[{"given":"Y.","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Matsuguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kajimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yujiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.01.079_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbmt.2005.07.005","article-title":"Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor","volume":"11","author":"Kanda","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.bmt.1705543","article-title":"Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation","volume":"39","author":"Inamoto","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12185-015-1836-7","article-title":"Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia","volume":"102","author":"Tachibana","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transproceed.2019.01.079_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2015-04-642652","article-title":"Efficiency of high-dose cytarabine added to CY\/TBI in cord blood transplantation for myeloid malignancy","volume":"126","author":"Arai","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2019.01.079_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13045-015-0201-x","article-title":"Clinical significance of high-dose cytarabine added to cyclophosphamide\/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy","volume":"8","author":"Arai","year":"2015","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.transproceed.2019.01.079_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbmt.2012.12.007","article-title":"Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies","volume":"19","author":"Mori","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbmt.2013.12.555","article-title":"Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission","volume":"20","author":"Konuma","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib8","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3324\/haematol.2014.114504","article-title":"Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan","volume":"99","author":"Konuma","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.transproceed.2019.01.079_bib9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.bbmt.2015.05.009","article-title":"Effect of granulocyte colony-stimulating factor-combined conditioning in cord blood transplantation for myelodysplastic syndrome and secondary acute myeloid leukemia: a retrospective study in Japan","volume":"21","author":"Konuma","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib10","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2019.01.079_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.transproceed.2019.01.079_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbmt.2008.03.006","article-title":"Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine","volume":"14","author":"Mori","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bmt.1705578","article-title":"Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience","volume":"39","author":"Mori","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2015.330","article-title":"Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Tanaka","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2019.01.079_bib17","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518311722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518311722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T21:10:22Z","timestamp":1555449022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518311722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0041134518311722"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.01.079","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.01.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}